Enliven Therapeutics (ELVN) Q3 2025 Earnings

Aug 13Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.57
-0.53
-0.5
-0.46

Details

Expected EPS
-0.536822
Actual EPS
-0.49
Surprise EPS
0.05
Surprise Percent
+8.72%

Description

⁨Enliven Therapeutics⁩ (⁦ELVN⁩) has reported earnings of ⁦-0.49⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts